NDA 065430 · B Braun
Cefotetan and Dextrose In Duplex Container
Cefotetan Disodium · Injection
DiscontinuedLast checked: Nov 20, 2026Latest source record: Jan 30, 2020 (newest FDA action)Source: Drugs@FDA, openFDA, CMS, ClinicalTrials.gov, PubMedMethods & limitations
First approved
2007
Aug 9, 2007
Approved uses
1
Original approval plus efficacy supplements
Registered trials
6
1 Phase 3, 1 recruiting
FAERS reports
0
0 serious, 0 with death reported
AI brief across all sources
Written by AI from the FDA, CMS, ClinicalTrials.gov, FAERS and PubMed data on this page, plus web searches for pricing, exclusivity and pending FDA decisions.
What it is approved for
No structured label for this application in openFDA. Older and discontinued products often have none.
Approval history
Original approval and efficacy supplements (new uses, populations or doses), newest first, with FDA's letters and labels.
- Aug 9, 2007 Original approval Letter
2 products under this application
- CEFOTETAN AND DEXTROSE IN DUPLEX CONTAINER · CEFOTETAN DISODIUM EQ 2GM BASE/VIAL · INJECTABLE, INJECTION · Discontinued
- CEFOTETAN AND DEXTROSE IN DUPLEX CONTAINER · CEFOTETAN DISODIUM EQ 1GM BASE/VIAL · INJECTABLE, INJECTION · Discontinued
Clinical trials
Interventional ClinicalTrials.gov studies with "Cefotetan Disodium" as an intervention, any sponsor and status, largest first.
- A Single Dose of a Marketed Drug Being Studied for a New Indication to Treat Surgical Site Infection Following Colorectal Surgery as Compared to a Marketed Drug Approved for This Indication (0826-039)Pivotal-lookingCompleted
Merck Sharp & Dohme LLCMerck & Co. (MRK)
NCT00090272 · 952 participants · Start Apr 2002 · Primary completion Mar 2005
Drug: MK0826, ertapenem sodium; Comparator: cefotetan · For: Colorectal Surgery
- Effectiveness of Prophylactic Antibiotics Therapy in Laparoscopic Cholecystectomy on Infection RatePivotal-lookingCompleted
Chonbuk National University HospitalAcademic, hospital or other
NCT04726046 · 529 participants · Start Apr 1, 2014 · Primary completion Aug 1, 2015
Drug: Cefotetan · For: Cholecystitis
National Cancer Center, KoreaGovernment (non-federal)
NCT01220661 · 312 participants · Start Oct 2010 · Primary completion Dec 2011
Drug: Cefotetan · For: Colorectal Surgery
Sites: Goyang-si, South Korea
- Antibiotics for Postpartum Third and Fourth Degree Perineal Tear RepairsPivotal-lookingCompleted
Stanford UniversityAcademic, hospital or other
NCT00186082 · 147 participants · Start Sep 2003 · Primary completion Jun 2006
Drug: Cefotetan or Cefoxitin vs placebo · For: Pregnancy Complications, Infectious
Sites: San Jose, California; Stanford, California
Oregon Health and Science UniversityAcademic, hospital or other
NCT07318584 · 50 participants (planned) · Start Jun 26, 2026 · Primary completion Oct 2028
Drug: Cefotetan; Carbapenems and 1 more · For: E Coli Infection; ESBL Producing E.Coli
Sites: Portland, Oregon
Julio RamirezAcademic, hospital or other
NCT02099240 · 11 participants · Start Mar 6, 2014 · Primary completion Nov 7, 2018
Drug: oral antibiotics · For: Osteomyelitis
Sites: Louisville, Kentucky
Most reported adverse reactions
FAERS reports naming this application or brand. Unverified reports, not rates; a report can name several drugs.
No FAERS reports name this application.
FAERS reports by year
By the date FDA received the report.
No reports.
Recalls
0 FDA enforcement reports for this application.
No recalls on record for this application.
Shortages
FDA's drug shortage list.
Not on FDA's shortage list.
Medicare spending
CMS Spending by Drug. Part D is pharmacy-dispensed; Part B is given in a clinic or hospital outpatient setting. Spending is before manufacturer rebates.
Not found under this brand name in Medicare's Part D or Part B Spending by Drug data. CMS lists some drugs under the generic name only.
Published evidence
PubMed clinical trials, meta-analyses and systematic reviews, most relevant first.
- Prophylactic antibiotics for elective laparoscopic cholecystectomy: are they necessary?
Higgins A, London J, Charland S, et al. · Arch Surg 1999 · Clinical Trial, Randomized Controlled Trial
- Cefotetan disodium (Cefotan).
· Med Lett Drugs Ther 1986 · Clinical Trial
- Pharmacokinetics and tolerance of single intravenous doses of cefotetan disodium in male Caucasian volunteers.
Yates RA, Adam HK, Donnelly RJ, et al. · J Antimicrob Chemother 1983 · Clinical Trial, Randomized Controlled Trial
- Pharmacokinetics and Tolerability of Single and Multiple Intravenous Doses of Cefotetan Disodium in Healthy Chinese Volunteers.
Liu J, Zhai Y, Wu L, et al. · Drug Des Devel Ther 2020 · Comparative Study, Randomized Controlled Trial
- Pharmacokinetics and tolerability of intravenous cefotetan disodium for injection in healthy Chinese volunteers: A randomized, open-label, single- and multiple-dose study.
Shi S, Liu Y, Li Z, et al. · Clin Ther 2010 · Randomized Controlled Trial, Research Support, Non-U.S. Gov't
- Pharmacokinetic differences between the epimers of cefotetan disodium after single intravenous injection in healthy Chinese volunteers.
Su MX, Liu MH, Di B, et al. · Eur J Drug Metab Pharmacokinet 2011 · Randomized Controlled Trial
Sponsor: B Braun
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.